1. 负责公司整体净利润和现金流优化2. 统筹管理战略、人力行政、财务、质量及供应链（2020年4月起）约50人的团队3. Business planning，预算体系制定及目标设定、sales&operation planning、价盘机制、产品合格指标设定及上下市决策机制、费用ROI评估及审核机制，及日常经营PDCA的管控4. Project management, 跨部门大项目管理及辅助CEO决策 5. 组织建设：人才盘点，OKR制定，晋升机制优化，管培生队伍建设，管理工具搭建等6. 投资人关系：月度经营分析，董事会筹备并列席7. 战略、市场、行业动态研究8. 公司创新项目孵化中心

在公司从A轮发展到B轮的过程中，先后负责用户及产品运营、客户服务与用户体验、招聘、PR等工作，实现了这些部门和体系从0到1的建设。主要成绩包括但不限于：• 用户及产品运营：作为第一个运营管理者，负责新用户转化、老用户留存、生命周期管理和收入贡献。用户积分及会员体系搭建，促销活动整体策划及落地，会员留存策略及实施，付费转化引导，商品推广策略及落地等• 客服：建立客服标准话术、知识库，公司内部工作SOP，客服服务标准等• PR：与30余家知名创投圈、财经及时尚媒体建立联系，完成10+篇一线媒体报道

• 在公司从B轮到D+轮的发展中，全面负责公司战略核心业务：商业化及流量变现模式探索• 从零开始搭建并管理电商事业部，达60余人规模，包括产品、技术、运营、采购、供应链、HRBP等全部业务职能• 电商系统于2015年3月上线，自上线后每个月的单量和销售额均保持在30%到200%的增长，各环节服务均达到行业标准水平1. In charge of the Corporate Development Department, responsible for developing the monetization strategy and business model for Dayima 2. Build up and manage a fully-functional business unit focusing on e-commerce from ground to currently 60 people3. Manage the overall operation and keep growing the business (the month to month growth is between 30% to 200%)

• 提供亚太各个细分市场的动向及趋势分析• 针对每个国家的需求和产品的具体情况制定市场策略，在亚太各国间分享最佳经验，并和公司全球的策略协同• 管理内窥镜附属及周边产品的生命周期，包括营销方案，销售渠道策略，CFDA注册流程，销售培训及销售分析• 参与制定并落实新战略拓展方案，包括建立产品在新疾病中的应用计划及收购候选公司的尽职调查• 与市场部共同策划市场活动，为医疗界的核心意见领袖介绍宾得医疗及宾得的产品和服务1. Provided market intelligence information to all Asia Pacific countries by collecting market data and develop analytics2. Developed marketing strategies specific for each country and product, share best practice and align with the global strategies3. Managed the life cycle of accessory and peripheral products, including the promotional plan, distribution strategy, registration coordination, sales analysis, and product training 4. Developed and executed new strategic initiatives such as building the product penetration plan in new disease areas5. Designed marketing events with marketing team colleagues to introduce Pentax and products to key opinion leaders (KOLs)

• 为国际知名医药/医疗仪器企业及新兴生物技术公司提供产品、市场营销、销售及并购等多方面战略方案• 作为团队核心成员完成7个项目，并参与支持了6个项目，得到了客户和内部团队的高度评价项目举例：• 为美国中型医药公司提供在新兴市场的流行病商业化机会评估（新兴市场包括巴西、俄罗斯、印度和中国）• 为一家跨国医药公司和一家医疗仪器公司做心血管疾病相关产品线的深度合作战略分析• 为美国生物技术公司的核心技术提供全球销售预测及并购评估Campbell Alliance is a management consulting company specialized in the pharmaceutical and biotech industry.1. Advise both established and emerging pharmaceutical and biotech clients2. Completed seven engagements and supported six projects, received highly positive feedback from both clients and internal teamSelected Engagements:• Commercialization Opportunities Assessment in Emerging Markets of infectious disease for a mid-sized US pharmaceutical company• Partnership Strategies between leading multinational pharmaceutical and medical device companies for a strategic portfolio asset for cardiovascular diseases• Product Launch Best Practice and Launch Management for both large pharmaceutical and small biotech companies

• 为国际知名医药/医疗仪器企业及新兴生物技术公司提供产品、市场营销、销售及并购等多方面战略方案• 支持公司的项目拓展，为公司带来了3个新项目和4个提案；并参与负责公司新员工的招募和内部培训项目举例：• 为美国一家领先医疗仪器公司做心血管仪器领域的增长策略• 为美国一家中型医药企业做第二代多发性骨髓瘤药物的新市场拓展及营销策略• 为美国一家生物技术公司的四项核心技术做市场战略定位• Supported company's business development and internal training initiatives. Business development research led to several new engagements proposals.Selected Engagements:1. Growth strategy for a US leading medical device company’s core heart valve devices 2. New Market Entry/Marketing Strategies for a US pharmaceutical company’s 2nd generation drug in multiple myeloma3. Strategic Positioning for a US biotech company’s four key assets in chronic myeloid leukemia (CML), gastrointestinal stromal tumor (GIST), metastatic cancer, and rheumatoid arthritis (RA)

Rao Lab, Behavioral Neuroscience• Developed the project “The sexual dimorphic function of dopamine in aggressive behavior in drosophila”• Organized, coordinated and emceed the Annual NIBS Gala, 500 people in attendance